Paper40985161
Luminescent Nanocucurbits Enable Spatiotemporal Co-Delivery of Hydrophilic and Hydrophobic Chemotherapeutic Agents.
Wei P and 4 others. Adv Sci (Weinh), 2025. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Luminescent Nanocucurbits Enable Spatiotemporal Co-Delivery of Hydrophilic and Hydrophobic Chemotherapeutic Agents. Papers, record 40985161. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40985161
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Luminescent Nanocucurbits Enable Spatiotemporal Co-Delivery of Hydrophilic and Hydrophobic Chemotherapeutic Agents.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Drug Delivery Systems | Major topic |
| Antineoplastic Agents | Major topic |
| Nanoparticles | Major topic |
| Nanostructures | Major topic |
| Hydrophobic and Hydrophilic Interactions | |
| Humans | |
| Doxorubicin | |
| Cell Line, Tumor | |
| Drug Carriers |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 22305102 | National Natural Science Foundation of China | PubMed | ||
| BK20221097 | Basic Research Program of Jiangsu | PubMed | ||
| KLCCB-KF202405 | Open Project of Key Laboratory of Carbohydrate Chemistry and Biotechnology (Jiangnan University), Ministry of Education | PubMed |
Source PubMed
References57
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 34175367 | Nanoplatform-based natural products co-delivery system to surmount cancer multidrug-resistant. | J Control Release | 2021 | https://conductscience.org/library/papers/34175367 | PubMed |
| 2 | 33609621 | Polymeric micelles in cancer therapy: State of the art. | J Control Release | 2021 | https://conductscience.org/library/papers/33609621 | PubMed |
| 3 | 39698747 | Biodegradable Nanobowls with Controlled Dents. | ACS Macro Lett | 2025 | https://conductscience.org/library/papers/39698747 | PubMed |
| 4 | 35931466 | Multicompartmental Microcapsules for Enzymatic Cascade Reactions Prepared through Gas Shearing and Surface Gelation. | Biomacromolecules | 2022 | https://conductscience.org/library/papers/35931466 | PubMed |
| 5 | 33500737 | Co-delivery of 5-fluorouracil and miRNA-34a mimics by host-guest self-assembly nanocarriers for efficacious targeted therapy in colorectal cancer patient-derived tumor xenografts. | Theranostics | 2021 | https://conductscience.org/library/papers/33500737 | PubMed |
| 6 | 34607478 | Co-delivery of sorafenib and crizotinib encapsulated with polymeric nanoparticles for the treatment of in vivo lung cancer animal model. | Drug Deliv | 2021 | https://conductscience.org/library/papers/34607478 | PubMed |
| 7 | 32316537 | Endocytosis: The Nanoparticle and Submicron Nanocompounds Gateway into the Cell. | Pharmaceutics | 2020 | https://conductscience.org/library/papers/32316537 | PubMed |
| 8 | 38604384 | Co-encapsulation of granzyme B and perforin in nanocapsules for tumour therapy: biomimicking immune cells. | J Control Release | 2024 | https://conductscience.org/library/papers/38604384 | PubMed |
| 9 | 38615388 | Dendritic polymer prodrug-based unimolecular micelles for pH-responsive co-delivery of doxorubicin and camptothecin with synergistic controlled drug release effect. | Colloids Surf B Biointerfaces | 2024 | https://conductscience.org/library/papers/38615388 | PubMed |
| 10 | 35820601 | Opportunities and challenges for co-delivery nanomedicines based on combination of phytochemicals with chemotherapeutic drugs in cancer treatment. | Adv Drug Deliv Rev | 2022 | https://conductscience.org/library/papers/35820601 | PubMed |
| 11 | 39688563 | A Polypeptosome Spray To Heal Antibiotic-Resistant Bacteria-Infected Wound by Photocatalysis-Induced Metabolism-Interference. | ACS Nano | 2024 | https://conductscience.org/library/papers/39688563 | PubMed |
| 12 | 33527954 | Short intrinsically disordered polypeptide-oligonucleotide conjugates for programmed self-assembly of nanospheres with temperature-dependent size controllability. | Soft Matter | 2021 | https://conductscience.org/library/papers/33527954 | PubMed |
| 13 | 26529199 | Co-delivery of drugs and plasmid DNA for cancer therapy. | Adv Drug Deliv Rev | 2016 | https://conductscience.org/library/papers/26529199 | PubMed |
| 14 | 24818887 | Enhanced antitumor efficacy of folate modified amphiphilic nanoparticles through co-delivery of chemotherapeutic drugs and genes. | Biomaterials | 2014 | https://conductscience.org/library/papers/24818887 | PubMed |
| 15 | 38309054 | Camptothesome-based combination nanotherapeutic regimen for improved colorectal cancer immunochemotherapy. | Biomaterials | 2024 | https://conductscience.org/library/papers/38309054 | PubMed |
| 16 | 40264332 | Preparation and Mechanism Insight of Biodegradable Kippah Vesicles. | Small | 2025 | https://conductscience.org/library/papers/40264332 | PubMed |
| 17 | 24875756 | Folding graft copolymer with pendant drug segments for co-delivery of anticancer drugs. | Biomaterials | 2014 | https://conductscience.org/library/papers/24875756 | PubMed |
| 18 | 25542535 | In situ DOX-calcium phosphate mineralized CPT-amphiphilic gelatin nanoparticle for intracellular controlled sequential release of multiple drugs. | Acta Biomater | 2015 | https://conductscience.org/library/papers/25542535 | PubMed |
| 19 | 38906204 | Improving hemocompatibility in tissue-engineered products employing heparin-loaded nanoplatforms. | Pharmacol Res | 2024 | https://conductscience.org/library/papers/38906204 | PubMed |
| 20 | 17312383 | The activity of caspases in spontaneous and camptothecin-induced death of melanotic and amelanotic melanoma cell. | Cancer Biol Ther | 2007 | https://conductscience.org/library/papers/17312383 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41754938 | Smart Nanoformulations for Oncology: A Review on Overcoming Biological Barriers with Active Targeting, Stimuli-Responsive, and Controlled Release for Effective Drug Delivery. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/41754938 | PubMed |
| 40985161 | Luminescent Nanocucurbits Enable Spatiotemporal Co-Delivery of Hydrophilic and Hydrophobic Chemotherapeutic Agents. | Adv Sci (Weinh) | 2025 | https://conductscience.org/library/papers/40985161 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40985161
GET https://conductscience.org/api/papers/v1/40985161/references?page=2